Search Results - "Xia, Junzhe"

  • Showing 1 - 8 results of 8
Refine Results
  1. 1

    LPS alters the immuno-phenotype of glioma and glioma stem-like cells and induces in vivo antitumor immunity via TLR4 by Han, Sheng, Wang, Chao, Qin, Xiaofei, Xia, Junzhe, Wu, Anhua

    “…This study examined the ability of lipopolysaccharide (LPS) to affect glioma and glioma stem-like cells (GSCs) in vitro and to induce antitumor immunity in…”
    Get full text
    Journal Article
  2. 2

    Lithium enhances the antitumour effect of temozolomide against TP53 wild-type glioblastoma cells via NFAT1/FasL signalling by Han, Sheng, Meng, Lingxuan, Jiang, Yang, Cheng, Wen, Tie, Xinxin, Xia, Junzhe, Wu, Anhua

    Published in British journal of cancer (09-05-2017)
    “…Background: We previously showed that activation of the nuclear factor of activated T cells (NFAT)1/Fas ligand (FasL) pathway induces glioma cell death…”
    Get full text
    Journal Article
  3. 3

    Vaccine injection site matters: qualitative and quantitative defects in CD8 T cells primed as a function of proximity to the tumor in a murine glioma model by Ohlfest, John R, Andersen, Brian M, Litterman, Adam J, Xia, Junzhe, Pennell, Christopher A, Swier, Lauryn E, Salazar, Andres M, Olin, Michael R

    Published in The Journal of immunology (1950) (15-01-2013)
    “…Malignant gliomas are lethal brain tumors for which novel therapies are urgently needed. In animal models, vaccination with tumor-associated Ags efficiently…”
    Get full text
    Journal Article
  4. 4
  5. 5

    Vasculogenic mimicry–potential target for glioblastoma therapy: an in vitro and in vivo study by Chen, Yinsheng, Jing, Zhitao, Luo, Cheng, Zhuang, Minghua, Xia, Junzhe, Chen, Zhongping, Wang, Yunjie

    “…Glioblastoma is one of the most angiogenic human tumors and characterized by microvascular proliferations. A better understanding of glioblastoma vasculature…”
    Get full text
    Journal Article
  6. 6

    CD200 in CNS tumor-induced immunosuppression: the role for CD200 pathway blockade in targeted immunotherapy by Moertel, Christopher L, Xia, Junzhe, LaRue, Rebecca, Waldron, Nate N, Andersen, Brian M, Prins, Robert M, Okada, Hideho, Donson, Andrew M, Foreman, Nicholas K, Hunt, Matthew A, Pennell, Christopher A, Olin, Michael R

    Published in Journal for immunotherapy of cancer (16-12-2014)
    “…Immunological quiescence in the central nervous system (CNS) is a potential barrier to immune mediated anti-tumor response. One suppressive mechanism results…”
    Get full text
    Journal Article
  7. 7

    Monomeric annexin A2 is an oxygen-regulated toll-like receptor 2 ligand and adjuvant by Andersen, Brian M, Xia, Junzhe, Epstein, Alan L, Ohlfest, John R, Chen, Wei, Blazar, Bruce R, Pennell, Christopher A, Olin, Michael R

    Published in Journal for immunotherapy of cancer (16-02-2016)
    “…Annexin A2 (ANXA2) is a pleiotropic, calcium-dependent, phospholipid-binding protein with a broad tissue distribution. It can be intracellular, membrane-bound,…”
    Get full text
    Journal Article
  8. 8

    Citadel: Protecting Data Privacy and Model Confidentiality for Collaborative Learning with SGX by Zhang, Chengliang, Xia, Junzhe, Yang, Baichen, Puyang, Huancheng, Wang, Wei, Chen, Ruichuan, Akkus, Istemi Ekin, Aditya, Paarijaat, Yan, Feng

    Published 04-05-2021
    “…With the advancement of machine learning (ML) and its growing awareness, many organizations who own data but not ML expertise (data owner) would like to pool…”
    Get full text
    Journal Article